Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia

Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia

- Comprehensive review of recent milestones highlights statistically significant efficacy in prostate cancer prevention, discovery of novel lipid-modulating properties, and the execution of high-value commercial partnerships in South Korea and...

Datasea Reports Second Fiscal Quarter 2026 Results

Datasea Reports Second Fiscal Quarter 2026 Results

Gross Profit Increased 284.4% Year-over-Year and Gross Margin Increases 730 Basis Points to 8.8% BEIJING, Feb. 12, 2026 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), a Nevada-based technology enterprise engaged in...

J INTS BIO Reports Fourth-Generation EGFR Inhibitor JIN-A02 in Clinical Cancer Research

J INTS BIO Reports Fourth-Generation EGFR Inhibitor JIN-A02 in Clinical Cancer Research

SEOUL, South Korea, Feb. 12, 2026 /PRNewswire/ -- J INTS BIO, Inc. announced that research findings on its investigational fourth-generation EGFR tyrosine kinase inhibitor (TKI), JIN-A02, have been published in Clinical Cancer Research, a leading...

NetEase Cloud Music Inc. Reports Fiscal Year 2025 Financial Results

NetEase Cloud Music Inc. Reports Fiscal Year 2025 Financial Results

HANGZHOU, China, Feb. 11, 2026 /PRNewswire/ -- NetEase Cloud Music Inc. (HKEX: 9899 or the "Company"), a leading interactive music streaming service provider in China, today announced its financial results for the fiscal year 2025 ended December 31,...

Youdao Reports Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

Youdao Reports Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

HANGZHOU, China, Feb. 11, 2026 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), an AI-powered solutions provider specializing in artificial intelligence applications for the learning and advertising verticals, today announced...

IRBM Reports Breakthrough in Zika Virus Drug Discovery

IRBM Reports Breakthrough in Zika Virus Drug Discovery

ROME, Feb. 10, 2026 /PRNewswire/ -- IRBM, a leader in early drug discovery research, has announced a major scientific breakthrough with the discovery of a novel and potent allosteric inhibitor targeting the Zika virus (ZIKV) protease (NS2B-NS3). The...

Ispire Technology Inc. Reports Financial Results for Fiscal Second Quarter 2026

Ispire Technology Inc. Reports Financial Results for Fiscal Second Quarter 2026

Ongoing Focus on Collections Drives 19% Reduction in Net Accounts Receivable since June 30, 2025 Cash of $17.6 Million at December 31, 2025 LOS ANGELES, Feb. 6, 2026 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company,"...

MGM China Reports 2025 Annual Results

MGM China Reports 2025 Annual Results

Revenue , Adjusted EBITDA and Marketshare Continued to Grow to All-Time High HONG KONG, Feb. 6, 2026 /PRNewswire/ -- MGM China Holdings Limited ("MGM China" or the "Company"; SEHK Stock Code: 2282) today announced the selected unaudited financial...

Agoda Reports Localization in Early Stages Lifts Guest Spend for 92% of Thailand Hotels

Agoda Reports Localization in Early Stages Lifts Guest Spend for 92% of Thailand Hotels

Insights from Agoda reveal how integrated, tailored guest experiences and digital partnerships are helping Thai hotels stand out amid rising regional travel SINGAPORE, Feb. 4, 2026 /PRNewswire/ -- Digital travel platform Agoda, in its latest...

Amcor Reports Solid Second Quarter Results and Reaffirms Fiscal 2026 Guidance

Amcor Reports Solid Second Quarter Results and Reaffirms Fiscal 2026 Guidance

Highlights - Three Months Ended December 31, 2025 Net sales $5,449 million, up 68% driven by the Berry acquisition GAAP Net income $177 million including acquisition related costs and GAAP diluted EPS of $0.38 Acquisition synergies of $55 million at...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • menu
    menu